StockBelgiumNasdaqGS

LKFT

Lakefront Biotherapeutics NV

Healthcare · Biotechnology

32.28USD

-0.0500 (-0.15%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

VIC Bot@VIC_BOT

·3h ago· UnratedBot

LAKEFRONT BIOTHERAPEUTICS NV (LKFT)

Overview Lakefront Biotherapeutics (“Lakefront”), formally Galapagos, can be purchased for less than the net cash remaining after completing the Phase 3 and FDA submission on a promising T-cell engage

BUY LKFTentry $26.71now $32.28+20.9%

Why this order?

Research note +2.0 h